Suppliers / Calox

Calox

Venezuela Updated 9 July 2026

Calox is a finished-dose manufacturer based in Venezuela. It appears in 792 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with INHRR (VE), DIGEMAPS (DO) and ARCSA (EC). Its most recent recorded inspection, by US FDA, closed on 31 October 2014 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 2 with an FDA FEI number
792
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 31 October 2014 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Chino Valley, United States 3031663773
Los Angeles, United States 2026523

Filings and GMP by regulator

Regulator Filings GMP certificates
INHRR (VE) 785 None
DIGEMAPS (DO) 4 None
ARCSA (EC) 3 None

Comparing suppliers?

Choose your molecules and target markets. Calox comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 31 October 2014.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability